Company Filing History:
Years Active: 2024
Title: Innovations of Ping-Ying Pan in Antibody Development
Introduction
Ping-Ying Pan is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions for targeting tumors and treating various diseases.
Latest Patents
Ping-Ying Pan holds a patent for "Anti-LILRB2 antibodies and methods of use thereof." This patent discloses antibodies and antibody fragments that specifically bind to LILRB2. The patent also includes compositions comprising these antibodies and methods of use. Additionally, it provides related chimeric antigen receptors (CARs) and cells that incorporate these receptors, such as T cells, natural killer cells, or macrophages. The applications of these CARs and cells include targeting tumors, treating asthma, removing infected cells, and suppressing immune system cells involved in autoimmune diseases or transplant rejection. He has 1 patent to his name.
Career Highlights
Throughout his career, Ping-Ying Pan has worked with prestigious institutions, including the Icahn School of Medicine at Mount Sinai and The Methodist Hospital. His research has contributed to advancements in medical treatments and therapeutic strategies.
Collaborations
Ping-Ying Pan has collaborated with various professionals in his field, including Shu-Hsia Chen. Their joint efforts have furthered research and development in antibody technology.
Conclusion
Ping-Ying Pan's innovative work in antibody development showcases his commitment to advancing medical science. His contributions have the potential to impact treatments for various diseases significantly.